Oral ATP citrate lyase inhibitor tablets, employed in cardiovascular and metabolic disorder treatment centers. Administered by specialists in clinics and hospitals for hyperlipidemia adjunct therapy. Acquired by healthcare providers from wholesalers in the pharmaceutical supply ecosystem.